31 – 40 of 107
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
(
- Contribution to journal › Article
-
Mark
Late-Life Depression Is Associated With Reduced Cortical Amyloid Burden : Findings From the Alzheimer's Disease Neuroimaging Initiative Depression Project
(
- Contribution to journal › Article
-
Mark
Polyoxometalates as Effective Nano-inhibitors of Amyloid Aggregation of Pro-inflammatory S100A9 Protein Involved in Neurodegenerative Diseases
(
- Contribution to journal › Article
- 2020
-
Mark
Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(39). p.24251-24257(
- Contribution to journal › Article
-
Mark
The role of fibril structure and surface hydrophobicity in secondary nucleation of amyloid fibrils
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(41). p.25272-25283(
- Contribution to journal › Article
-
Mark
Kinetic diversity of amyloid oligomers
(
- Contribution to journal › Article
-
Mark
Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein
(
- Contribution to journal › Article
-
Mark
Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?
(
- Contribution to journal › Article
-
Mark
Relevance of biomarkers across different neurodegenerative
(
- Contribution to journal › Scientific review
-
Mark
Secondary Nucleation in Amyloid Formation
2020)(
- Thesis › Doctoral thesis (compilation)